Science Daily -
17 Jun 2022 16:18
The mechanism by which active inflammation occurs in parallel with immunosuppression in the tumor microenvironment has been identified. Results showed reduced gene expression of regulatory T cell involved in immunosuppression. Cancer treatment employing EP2/EP4 inhibitors might benefit some cancer patients.
Share this Article